Hector R. Mendez-Figueroa | UT ...

Dr. Hector Mendez-Figueroa, MD

Claim this profile

University of Texas - Houston

Studies Obstetric Complications
Studies Intrauterine Growth Restriction
6 reported clinical trials
10 drugs studied

Affiliated Hospitals

Image of trial facility.

University Of Texas - Houston

Image of trial facility.

The University Of Texas Health Science Center At Houston

Clinical Trials Hector Mendez-Figueroa, MD is currently running

Image of trial facility.

Azithromycin

for Reducing Infections After C-Section

This is a phase-III multi-center double-blind randomized controlled trial of 8,000 individuals undergoing a scheduled or prelabor cesarean delivery who are randomized to either adjunctive azithromycin prophylaxis or to placebo. Both groups also will receive standard of care preoperative antibiotics (excluding azithromycin). The primary endpoint is a maternal infection composite defined as any one of the following up to 6 weeks postpartum: endometritis, wound infection, abscess, septic thrombosis, sepsis, pneumonia, pyelonephritis and breast infection.

Recruiting

1 award

Phase 3

1 criteria

Image of trial facility.

Metformin vs Insulin

for Gestational Diabetes

This is a non-inferiority patient-centered and pragmatic comparative-effectiveness pregnancy randomized controlled trial (RCT) with postpartum maternal and child follow-up through 2 years of 1,572 individuals with gestational diabetes mellitus (GDM) randomized to oral metformin versus injectable insulin. This study will determine if metformin is not inferior to insulin in reducing adverse pregnancy outcomes, is comparably safe for exposed individuals and children, and if patient-reported factors, including facilitators of and barriers to use, differ between metformin and insulin. A total of 1,572 pregnant individuals with GDM who need pharmacotherapy will be recruited at 20 U.S. sites using consistent treatment criteria to metformin versus insulin. Participants and their children will be followed through delivery to two years postpartum.

Recruiting

3 awards

Phase 4

2 criteria

More about Hector Mendez-Figueroa, MD

Clinical Trial Related

4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Hector Mendez-Figueroa, MD has experience with

  • Ultrasound Following The ISUOG Guidelines
  • Ultrasound Following The SMFM Guidelines
  • Observational Study
  • Continuous Positive Airway Pressure
  • Arabin Pessary
  • Placebo

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Hector Mendez-Figueroa, MD specialize in?

Is Hector Mendez-Figueroa, MD currently recruiting for clinical trials?

Are there any treatments that Hector Mendez-Figueroa, MD has studied deeply?

What is the best way to schedule an appointment with Hector Mendez-Figueroa, MD?

What is the office address of Hector Mendez-Figueroa, MD?

Is there any support for travel costs?